Importantly, it equipped researchers with the means to explore the intricate signaling pathways at play within glioblastomas, shedding light on the potential hyperactivation of CDK5 and CDK4 in specific cell lines, like U87, or in tumor biopsies. Here, CDK5 is linked to glioblastoma.